← FDA Drug Approvals (Drugs@FDA)

MESALAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANNORA PHARMA · Approved 2020-03-19

Drug application

FDA Application #

ANDA213377

Application type

Abbreviated New Drug Application (Generic)

Brand name

MESALAMINE

Generic name

MESALAMINE

Active ingredients

MESALAMINE

Dosage form

SUPPOSITORY

Route

RECTAL

Marketing status

Prescription

Sponsor

ANNORA PHARMA

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2020-03-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown